UC San Diego joins national trial to explore new vaccines for COVID-19 variants | University of California
Volunteers needed for COVID-19 booster trial | KPWHRI
Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial - The Lancet
Volunteers sought for vaccine trial of COVID-19 booster | Newsroom
UMass Medical School to participate in trial of Pfizer COVID-19 booster vaccine
Immune response to SARS-CoV-2 after a booster of mRNA-1273: an open-label phase 2 trial | Nature Medicine
Moderna starts trial for Omicron-specific booster shot | Reuters
third covid vaccine booster trial | University of Southampton
Washington University participates in clinical trial of Moderna omicron booster – Washington University School of Medicine in St. Louis
Baylor launches clinical trial for COVID-19 vaccine booster | BCM
A Bivalent Omicron-Containing Booster Vaccine against Covid-19 | NEJM
Volunteers needed for expanded COVID-19 booster trial | KPWHRI
Skin Hydrating Booster Trial - Bio Aesthetic
Updated results from COVID-19 vaccine booster trial | KPWHRI
Funding for immunocompromised COVID-19 booster trial | UNSW Newsroom
Global-first COVID-19 vaccine booster trial launches in Bradford – Bradford Teaching Hospitals NHS Foundation Trust
New global vaccine trial launched to evaluate fractional COVID-19 booster shots - Murdoch Children's Research Institute
MultiCare launches COVID-19 vaccine booster trial - Newsroom
Safety, immunogenicity and antibody persistence of a bivalent Beta-containing booster vaccine against COVID-19: a phase 2/3 trial | Nature Medicine
UK launches extensive trial of third booster shots of Covid vaccines
Moderna on X: "In a Phase 2/3 trial in over 500 adults, mRNA-1273.222, induced significantly higher neutralizing antibody titers against BA.4/BA.5 compared to a booster dose of mRNA-1273. Read more: https://t.co/CPnxL03nZW https://t.co/ODihw6qtsQ" /
Cambridge begins world-first COVID-19 vaccine booster study - NIHR - Cambridge Clinical Research Facility
Moderna COVID-19 booster clinical trial starting at UMass Chan
